Brivanib
Brivanib Uses, Dosage, Side Effects, Food Interaction and all others data.
Brivanib is under investigation for the treatment of HepatoCellular Carcinoma. Brivanib has been investigated for the treatment of Solid Tumors, Hepato Cellular Carcinoma (HCC), and Metastatic Colorectal Cancer (MCRC).
| Trade Name | Brivanib |
| Generic | Brivanib |
| Brivanib Other Names | Brivanib |
| Type | |
| Formula | C19H19FN4O3 |
| Weight | Average: 370.384 Monoisotopic: 370.144118651 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Brivanib
